Method for treating glucose related disorders using stem cell-derived gastro-intestinal cells
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/342,029, filed Apr 7, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,398,737 | Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells In force · Low confidence | Incube Labs, LLC | In force | Low confidence | ||
| US 11,077,146 | Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells In force · Low confidence | Incube Labs, LLC | In force | Low confidence | ||
| US 9,144,586 | Method for treating glucose related disorders using stem cell-derived gastro-intestinal cells In force · High confidence | Incube Labs, LLC | In force | High confidence | ||
| US 12,115,195 | Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells In force · Low confidence | Incube Labs, LLC | In force | Low confidence | ||
| US 9,617,518 | Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells Lapsed Apr 11, 2025 on the fee record High confidence | Incube Labs, LLC | Lapsed Apr 11, 2025 on the fee record | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Incube Labs, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.